- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Lenvatinib is a multi-target tyrosine kinase inhibitor mainly used to treat malignant tumors such as thyroid cancer, hepatocellular carcinoma, ...
The use of Lenvatinib should focus on adverse reactions such as hypertension and proteinuria, and regular monitoring and adjustment of dosage a...
Tucatinib is an anticancer drug targeting HER2 protein, which is mainly used to treat HER2 positive breast cancer and colorectal cancer. Its si...
The use of Tucatinib should focus on preventing diarrhea, hepatotoxicity, and reproductive risks. The dosage should be adjusted according to to...
Entrectinib, as a TRK/ROS1 inhibitor, should be used with a focus on neurological toxicity, cardiac risk, and special population management. Th...
Entrectinib, as a TRK/ROS1 inhibitor, commonly has side effects involving the nervous system, cardiovascular system, and digestive system, requ...
Upadacitinib, as a JAK1 inhibitor, should be used with a focus on infection risk, thrombotic events, laboratory indicator monitoring, and speci...
Upadacitinib, as a JAK inhibitor, commonly has side effects such as increased risk of infection and gastrointestinal reactions, which require t...
The contraindications of Crizotinib mainly involve specific drug interactions, severe underlying diseases, and special physiological states, ...
The medication precautions for Crizotinib involve multiple aspects such as liver function monitoring, cardiovascular risk management, and medic...
